Opus Genetics
IRD
36 hedge funds and large institutions have $7.15M invested in Opus Genetics in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 4 closing their positions.
123% more capital invested
Capital invested by funds: $3.21M → $7.15M (+$3.94M)
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
6% more funds holding
Funds holding: 34 → 36 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$4.58M |
| 2 |
Renaissance Technologies
New York
|
+$145K |
| 3 |
CCM
Condor Capital Management
Martinsville,
New Jersey
|
+$50.3K |
| 4 |
AT
Arden Trust
Wilmington,
Delaware
|
+$17.3K |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$13K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SBIA
Sheaff Brock Investment Advisors
Indianapolis,
Indiana
|
-$25K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$15.1K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
-$9.82K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$7.32K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LTFS
26
Ladenburg Thalmann Financial Services
Miami,
Florida
| $3K | +$666 | +4 | +22% |
|
27
Bank of America
Charlotte,
North Carolina
| $3K | +$2.83K | +17 | New |
|
28
Wells Fargo
San Francisco,
California
| $2K | +$2K | +12 | New |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| $1K | -$333 | -2 | -22% |
|
|
CP
30
Corbenic Partners
Bethlehem,
Pennsylvania
| $1K | – | – | – |
|
31
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$666 | +4 | +133% |
|
32
Geode Capital Management
Boston,
Massachusetts
| $302 | – | – | – |
|
|
SBIA
33
Sheaff Brock Investment Advisors
Indianapolis,
Indiana
| – | -$25K | -145 | Closed |
|
|
34
Creative Planning
Overland Park,
Kansas
| – | -$9.82K | -59 | -98% |
|
|
35
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$7K | -38 | Closed |
|
36
Citadel Advisors
Miami,
Florida
| – | -$6K | -35 | Closed |
|
|
HF
37
Hoxton Financial
Shepherdstown,
West Virginia
| – | -$166 | -1 | -50% |
|
IRD Hedge Fund Activity: Q1 2016 in Review
36 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q1 2016, worth a combined $7.15M — up 123% from $3.21M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new IRD positions and 4 closed out — a net gain of 2 holders — while 7 added to existing stakes and 5 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $4.58M. The largest seller was Sheaff Brock Investment Advisors, exiting entirely with an estimated $25K sold.
- 36 institutional investors held Opus Genetics (IRD) as of Q1 2016, up from 34 in Q4 2015.
- Funds reported $7.15M of Opus Genetics stock for Q1 2016, up 123% quarter-over-quarter.
- 6 funds opened new Opus Genetics positions in Q1 2016 and 4 closed out, a net change of +2 holders.
- The largest Opus Genetics buyer in Q1 2016 was Sabby Management, an estimated $4.58M added.
- The largest Opus Genetics seller in Q1 2016 was Sheaff Brock Investment Advisors, an estimated $25K sold.
Based on aggregated 13F filings for Q1 2016.